Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001489|
Recruitment Status : Completed
First Posted : December 10, 2002
Last Update Posted : March 4, 2008
This study is designed to test the effects of vigabatrin (gamma-vinyl-GABA) an experimental drug used for the treatment of epilepsy. The study will use positron emission tomography (PET scan) to detect areas of the brain receiving increased blood flow and using increased amounts of glucose. Increases in blood flow and glucose use are good indicators of brain activity.
Researchers are interested in determining the effects of Vigabatrin on brain blood flow and glucose use.
|Condition or disease|
|Epilepsy Epilepsy, Complex Partial|
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||The Effect of Vigabatrin on Cerebral Blood Flow and Glucose Metabolism|
|Study Start Date :||October 1994|
|Estimated Study Completion Date :||August 2000|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001489
|United States, Maryland|
|National Institute of Neurological Disorders and Stroke (NINDS)|
|Bethesda, Maryland, United States, 20892|